NCT04653142 - A Study to Test Different Doses of BI 765063 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer (Solid Tumors) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

April 20, 2022

Study Completion Date

April 20, 2022

Conditions

Solid Tumors

Interventions

DRUG

BI 765063

DRUG

BI 754091

Trial Locations (4)

National Cancer Center Hospital East, Chiba, Kashiwa

Shikoku Cancer Center, Ehime, Matsuyama

Osaka International Cancer Institute, Osaka, Osaka

National Cancer Center Hospital, Tokyo, Chuo-ku